Alzheimer's pathology has been linked to decreased levels of Aβ42 and elevated levels of t-tau and p-tau in the CSF, which may be beneficial in the early identification of the disease [29]. More biomarkers are being researched to diagnose Alzheimer's disease early. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.